Seattle WA (SPX) May 20, 2008 - Calypso Medical has announced that the U.S. Food and Drug Administration (FDA) cleared a new indication for the use of implantable Beacon electromagnetic transponders with the Calypso System in external beam radiation therapy.
[read full story]
NEW YORK (CBS) ― Men with prostate cancer are often forced to choose between surgery or radiation treatments, but new technology is helping radiation become safer and more effective. Its a variation on a device you may have in your car. GPS helps you find your way around an unfamiliar area....
Posted on: Monday, 19 May 2008, 09:01 CDT Calypso(R) Medical announced today that the U.S. Food and Drug Administration (FDA) cleared a new indication for the use of implantable Beacon(R) electromagnetic transponders with the Calypso System in external beam radiation therapy. Known as GPS for the...
SEATTLE--(BUSINESS WIRE)--Calypso Medical announced today that the U.S. Food and Drug Administration (FDA) cleared a new indication for the use of implantable Beacon electromagnetic transponders with the Calypso System in external beam radiation therapy. Known as GPS for the Body, the Calypso...
Posted on: Tuesday, 20 May 2008, 09:01 CDT Calypso Medical has announced that the FDA cleared a new indication for the use of implantable Beacon electromagnetic transponders with the Calypso System in external beam radiation therapy. Known as GPS for the Body, the Calypso System utilizes...
By Steven Reinberg HealthDay Reporter TUESDAY, May 20 (HealthDay News) -- Men with advanced prostate cancer that hasn't spread beyond the gland should receive radiation therapy as soon as the prostate has been removed, a new long-term study says. "What we are showing today is that there is a...
who did not," he said. Prostate-specific antigen (PSA) is a protein produced by the cells in the prostate; because PSA can be used to detect disease, it is sometimes called a biological marker or tumor marker, according to the National Cancer Institute. The examinations included PSA measurements...
Calypso(R) Medical announced that the U.S. Food and Drug Administration (FDA) cleared a new indication for the use of implantable Beacon® electromagnetic transponders with the Calypso System in external beam radiation therapy. Known as GPS for the Body®, the Calypso System utilizes transponders...